# Study of Rituximab Monotherapy on Children With New-onset Nephrotic Syndrome: A Randomized Controlled Trial

> **NCT05734794** · PHASE3 · RECRUITING · sponsor: **The Children's Hospital of Zhejiang University School of Medicine** · enrollment: 80 (estimated)

## Conditions studied

- Nephrotic Syndrome in Children
- Rituximab

## Interventions

- **DRUG:** Rituximab
- **DRUG:** Steroid

## Key facts

- **NCT ID:** NCT05734794
- **Lead sponsor:** The Children's Hospital of Zhejiang University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-02-09
- **Primary completion:** 2025-12-25
- **Final completion:** 2026-07-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2023-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05734794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05734794, "Study of Rituximab Monotherapy on Children With New-onset Nephrotic Syndrome: A Randomized Controlled Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05734794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*